Merck (MRK) Tops Q2 EPS by 14c, Beats on Revenue; Offers FY26 EPS Guidance
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $148.78 +0.54%
EPS Growth %: -14.3%
Financial Fact:
Equity income from affiliates: -2.5B
Today's EPS Names:
OCCI, IPX, ALZN, More
EPS Growth %: -14.3%
Financial Fact:
Equity income from affiliates: -2.5B
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q2 EPS of ($0.13), $0.14 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $16.6 billion versus the consensus estimate of $16.41 billion.
GUIDANCE:
Merck sees FY2026 EPS of $2.66-$2.76, versus the consensus of $2.76.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
- Pentagon-Backed Oil Company Is Set to Vie for Chevron's Crown in Venezuela - WSJ
- Future Money Acquisition gets Nasdaq notice over late 10-Q filing
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
